Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radient Technologies Inc V.RTI.H

Alternate Symbol(s):  RDDTF

Healthcare Drug Manufacturers - Major Cannabis Cannabis
Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Radient Technologies Inc > FSD Pharma Covid19 clinical trials 💊🩹🎉
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(18)
•••
Comment by MJstockportfolion Jun 13, 2020 7:39pm
91 Views
Post# 31147436

RE:FSD Pharma Covid19 clinical trials 💊🩹🎉

RE:FSD Pharma Covid19 clinical trials 💊🩹🎉Like i said before you would have to be fully retarded to invest in FSD!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities